The influence of 1.2 μT, 60 Hz magnetic fields on melatonin- and tamoxifen-induced inhibition of MCF-7 cell growth

Bioelectromagnetics

Volumn 22, Issue 2, 2001, Pages 122-128

  Blackman, C F ^a   Benane, S G ^a   House, D E ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Breast cancer; ELF; In vitro; Replication study

Indexed keywords

ASSAYS; CANCER CELLS; CELL CULTURE; CELL PROLIFERATION; DISEASES; GROWTH KINETICS; MAGNETIC FIELDS;

BREAST CANCER; CELL NUMBER; CELL-BE; CELL/B.E; CELL/BE; ELF; IN-VITRO; MAGNETIC-FIELD; REPLICATION STUDY; TAMOXIFEN;

CELL GROWTH;

MINK CELL FOCUS-FORMING VIRUS;

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; MELATONIN; TAMOXIFEN;

ARTICLE; BREAST TUMOR; CELL CULTURE; CELL DIVISION; DRUG EFFECT; FEMALE; HUMAN; MAGNETISM; PATHOLOGY;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CELL DIVISION; FEMALE; HUMANS; MAGNETICS; MELATONIN; TAMOXIFEN; TUMOR CELLS, CULTURED;

EID: 0035261282     PISSN: 01978462     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-186X(200102)22:2<122::AID-BEM1015>3.0.CO;2-V     Document Type: Article

References (43)

1. Blackman CF, Benane SG, House DE, Pollock, MM. 1993. Action of 50 Hz magnetic fields on neurite outgrowth in Pheochmmocytoma cells. Bioelectromagnetics, 14:273-286.
2. Bignon E, Pons M, Dora JC, Gilbert J, Ojasoo T, Miquel JF, Raynaud JP, de Paulet AC. 1991. Influence of di- and triphenylethlene estrogen/antiestiogen structure on the mechanisms of protein kinase C inhibition and activation as revealed by multivariate analysis. Biochem Pharmacol 42:1373-1383.
3. Blask DE. 1993. Melatonin in oncology. In: Yu H-S, Reiter RJ, editors. Melatonin: biosynthesis, physiological effects, and clinical applications. Boca Raton, Florida: CRC Press. p 448-475.
4. Clarke R, van den Berg HW, Murphy RF. 1990. Reduction of the membrane fluidity of human breast cancer cells by tamoxifen and 17beta-estradiol. J Nat Cancer Inst 82:1702-1705.
5. Coezy E, Borgna JL, Rochefort H. 1982. Tamoxifen and metabolites in MCF-7 cells: correlation between binding to estrogen receptor and inhibit on of cell growth. Cancer Res 42:317-323.
6. Daniels WM, van Rensburg SJ, van Zyl JM, van der Walt BJ, Taljaard JJ. 1996. Free radical scavenging effects of melatonin and serotonin: possible mechanism. Neuroreport 7:1593-1596.
7. Ecker RL, Katzenellenbogen BS. 1983. Physical properties of estrogen receptor complexes in MCF-7 human breast cancer cells. J Biol Chem 257:8840-8846.
8. Einot I, Gabriel, KR. 1975. A study of the powers of several methods of multiple comparisons. J Am Stat Assoc 70:574-583.
9. Garcia JJ, Reiter RJ, Guerrero JM, Escames G, Yu BP, Oh CS, Munoz-Hoyos A. 1997. Melatonin prevents changes in microsomal membrane fluidity during induced lipid peroxidation. FEBS Lett 408:297-300.
10. Garcia JJ, Reiter RJ, Cabrera JJ, Pie J, Mayo JC, Sainz RM, Tan D, Qi W, Acuna-Castroviejo D. 2000. 5-methoxtryptophol preserves hepatic microsomal membrane fluidity during oxidative stress. J Cell Biochem 76:651-657.
11. Godson C, Reppert SM. 1997. The Mel la melatonin receptor is coupled to parallel signal transduction pathways. Endocrinology 138:397-404.
12. Harland JD, Liburdy RP. 1997. Environmental magnetic fields inhibit the antiproliferative action of tamoxifen and melatonin in a human breast cancer cell line. Bioelectromagnetics 18:555-562.
13. Hill SM, Blask DE. 1988. Effects of pineal hormone melatonin on the proliferalion and morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res 48:6121-6126.
14. Horgan K, Cooke E, Hallett MB, Mansel RE. 1986. Inhibition of protein kinase C mediated signal transduction by tamoxifen. Biochem Pharmacol 35:4463-4465.
15. Issandou M, Faucher C, Bayard F, Dardon JM. 1990. Opposite effects of tamoxifen on in vitro protein kinase C activity and endogenous protein phosphorylation in intact MCF-7 cells. Cancer Res 50:5845-5850.
16. Kojima T, Mochizuki C, Mitaka T, Mochizuky Y. 1997. Effects of melatonin on proliferation, oxidative stress and Cx32 gap junction protein expression in primary cultures of adult rat hepatocytes. Cell Struc Func 22:347-356.
17. Liburdy RP, Sloma TS, Sokolic R, Yaswen P. 1993a. ELF magnetic fields, breast cancer, and melatonin: 60 Hz fields block melatonin's oncostatic action on ER+ breast cancer cell proliferation. J Pineal Res 14:89-97.
18. Liburdy RP, Sokolic R, Yaswen P. 1993b. ELF magnetic fields and melatonin-induced growth of ER+ breast cancer cells. In Blank M, editor. Electricity and magnetism in biology and medicine. San Francisco: San Francisco Press. p 398-400.
19. Liburdy RP, Harland JD, Heffernan C, Seeley M, Dunham EE. 1994. ELF inhibition of melatonin's natural oncostatic action on MCF-7 cells: 60 Hz dose threshold determination. Abstract F-1-7, the Sixteenth Annual Meeting of the Bioelectromagnetics Society, June 12-17, 1994, Copenhagen, Denmark, p 51.
20. Lissoni P, Barni S, Cattaneo G, Tancini G, Esposti G, Esposti D. Fraschini F. 1991. Clinical results with the pineal hormone melatonin in advanced cancer resistant to standard antitumor therapies. Oncology 48:448-450.
21. 2+-dependent binding of tamoxifen to calmodulin isolated from bovine brain. Cancer Res 50:2753-2758.
22. Luben RA, Saraiya S, Morgan AP. 1996. Replication of 12 mG EMF effects on melatonin responses of MCF-7 breast cancer cells in vitro. Abstract A-1, the 1996 Annual review of research on biological effects of electric and magnetic fields from the generation, delivery and use of electricity, November 17-21, San Antonio, TX, p 1.
23. Luben RA, Morgan AP. 1998. Independent replication of 60 Hz, 1.2 μT EMF effects on melatonin and tamoxifen responses of MCF-7 breast cancer cells in vitro. Abstract A-3.4, Bioelectromagnetics Society Annual Meeting, St. Pete Beach, FL, 7-11 June, p 17-18.
24. McArthur AJ, Hunt AE, Gillette MU. 1997. Melatonin action and signal transduction in the rat suprachiasmatic circadian clock: activation of protein kinase C at dusk and dawn. Endocrinology 138:627-634.
25. MacGregor HI, Jordan VC. 1998. Basic guide to the mechanisms of antiestrogen action. Pharmacol Rev 50:151-196.
26. Molis TM, Spriggs LL, Jupiter Y, Hill SM. 1995 Melatonin modulation of estrogen-regulated proteins, growth factors, and proto-oncogenes in human breast cancer. J Pineal Res 18:93-103.
27. Morgan PJ, Davidson G, Lawson W, Barret P. 1990. Both pertussis toxin-sensitive and insensitive G-proteins link melatonin receptor to inhibition of adenylate cyclase in the ovine pars tuberaus. J Neuroendocrinol 2:773-776.
28. Morris JE, Chrisler WB, Miller DL, Sasser LB, Anderson LA. 1998. In vitro exposure of MCF-7 human mammary cells to 60 Hz magnetic fields. Abstract p-125A, Bioelectromagnetics Society Annual Meeting, St. Pete Beach, FL. 7-11 June, pp 204-205.
29. O'Brian CA, Liskamp RM, Solomon DH, Weinstein IB. 1985. Inhibition of protein kinase C by tamoxifen. Cancer Res 45:2462-2465.
30. O'Brian CA, Liskamp RM, Solomon DH, Weinstein IB. 1986. Triphenylethlenes: a new class of protein kinase inhibitors. J Natl cancer Inst 76:1243-1246.
31. O'Brian CA, Housey GM, Weinstein IB. 1988. Role of specific interactions between protein kinase C and triphenylethylenes in inhibition of the enzymes. J Nat Cancer Inst 18:1628-1633.
32. Reiter R. 1992. The ageing pineal gland and its physiological consequences. Bioessays 14:169-175.
33. Reiter R. 1994. Pineal function during aging: attenuation of the melatonin rhythm and its neurobiological consequences. Acta Neurobiol Exp 54(suppl):31-39.
34. Rowlands MG, Budworgth J, Jarman M, Hardcastle IR, McCague R, Gescher A. 1995. Comparison between inhibition of protein kinase C and antagonism of calmodulin by tamoxifen analogues. Biochem Pharmacol 50:723-726.
35. Ryan TA. 1960. Significance tests for multiple comparison of proportions, variances, and other statistics. Psychol Bull 57:318-328.
36. Tamarkin L, Cohen M, Roselle D, Reichter C, Lippman M, Chabner B. 1981. Melatonin inhibition and pinealectomy enhancement of 7-12-dimethylbenz(a)-anthracene-induced mammary tumors in rat. Cancer Res 41:4432-4436.
37. Vanecek J, Vollrath L. 1989. Melatonin inhibits cyclic AP and cyclic GMP accumulation in the rat pituitary. Brain Res 505:157-159.
38. Vanecek J, Vollrath L. 1990. Melatonin modulates diacylglycerol and arachidonic acid metabolism in the anterior pituitary of immature rats. Neurosci Lett 110:199-203.
39. 2+ in neonatal rat pituitary cells. Endocrinology 130:701-707.
40. Vanecek J, Klein DC. 1992b. Sodium-dependent effects of melatonin on membrane potential of neonatal rat pituitary cells. Endocrinology 131:939-946.
41. Vanecek J. 1995. Melatonin inhibits increase of intracellular calcium and cyclic AMP in neonatal rat pituitary via independent pathways. Mol Cell Endocrinol 107: 149-153.
42. Welsch RE. 1977. Stepwise multiple comparison procedures. J Am Stat Assoc 72:566-575.
43. + current in pituitary cell of newborn rats. Neuroendocrinology 65:276-283.